The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121424512 12142451 2 F 201512 20160830 20160303 20160912 EXP FR-APOPHARMA USA, INC.-2016AP006788 APOTEX 52.89 YR F Y 0.00000 20160912 CN SE FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121424512 12142451 1 PS FERRIPROX DEFERIPRONE 1 Oral 1500 MG, TID Y 21825 1500 MG TABLET TID
121424512 12142451 2 SS SIKLOS HYDROXYUREA 1 1000 MG, UNKNOWN Y N 0 1000 MG
121424512 12142451 3 SS SIKLOS HYDROXYUREA 1 500 MG, QD Y N 0 500 MG
121424512 12142451 4 SS DESFERAL DEFEROXAMINE MESYLATE 1 Subcutaneous 3 G, BID Y U 0 3 G BID
121424512 12142451 5 SS AUGMENTIN AMOXICILLINCLAVULANATE POTASSIUM 1 Oral UNK 0
121424512 12142451 6 SS TAVANIC LEVOFLOXACIN 1 Oral UNK 0
121424512 12142451 7 C LAROXYL AMITRIPTYLINE 1 Oral 40 MG, UNKNOWN U 0 40 MG
121424512 12142451 8 C PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 Oral 200 MG, BID U 0 200 MG BID
121424512 12142451 9 C SPECIAFOLDINE FOLIC ACID 1 Oral 5 MG, QD U 0 5 MG
121424512 12142451 10 C BIPROFENID KETOPROFEN 1 Oral 50 MG, TID U 0 50 MG TID
121424512 12142451 11 C TOPALGIC /00599202/ TRAMADOL 1 Oral 50 MG, TID U 0 50 MG TID
121424512 12142451 12 C LAMALINE /00764901/ ACETAMINOPHENBELLADONNA LEAFCAFFEINEMORPHINE 1 Oral UNK, PRN U 0
121424512 12142451 13 C INORIAL BILASTINE 1 Oral 20 MG, UNKNOWN U 0 20 MG
121424512 12142451 14 C COVERSYL /00790703/ PERINDOPRIL 1 Oral 5 MG, QD U 0 5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121424512 12142451 1 Sickle cell anaemia
121424512 12142451 2 Product used for unknown indication
121424512 12142451 4 Product used for unknown indication
121424512 12142451 5 Infection
121424512 12142451 6 Infection
121424512 12142451 7 Product used for unknown indication
121424512 12142451 8 Arthritis
121424512 12142451 9 Product used for unknown indication
121424512 12142451 10 Product used for unknown indication
121424512 12142451 11 Product used for unknown indication
121424512 12142451 12 Product used for unknown indication
121424512 12142451 13 Product used for unknown indication
121424512 12142451 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
121424512 12142451 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
121424512 12142451 Asthenia
121424512 12142451 Epistaxis
121424512 12142451 Pancytopenia
121424512 12142451 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121424512 12142451 1 20150721 20151229 0
121424512 12142451 3 201602 0
121424512 12142451 4 20150721 20151229 0
121424512 12142451 5 20151127 20151211 0
121424512 12142451 6 20151127 20151211 0
121424512 12142451 8 20150630 0
121424512 12142451 14 20150701 0